Annual Total Liabilities
$15.21 M
-$11.26 M-42.53%
December 31, 2024
Summary
- As of March 5, 2025, PMVP annual total liabilities is $15.21 million, with the most recent change of -$11.26 million (-42.53%) on December 31, 2024.
- During the last 3 years, PMVP annual total liabilities has fallen by -$7.80 million (-33.90%).
- PMVP annual total liabilities is now -91.23% below its all-time high of $173.51 million, reached on December 31, 2019.
Performance
PMVP Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Liabilities
$15.21 M
-$10.38 M-40.56%
December 31, 2024
Summary
- As of March 5, 2025, PMVP quarterly total liabilities is $15.21 million, with the most recent change of -$10.38 million (-40.56%) on December 31, 2024.
- Over the past year, PMVP quarterly total liabilities has dropped by -$10.38 million (-40.56%).
- PMVP quarterly total liabilities is now -91.23% below its all-time high of $173.51 million, reached on December 31, 2019.
Performance
PMVP Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
PMVP Total Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -42.5% | -40.6% |
| 3 y3 years | -33.9% | -35.0% |
| 5 y5 years | -91.2% | -35.0% |
PMVP Total Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -42.5% | at low | -42.5% | at low |
| 5 y | 5-year | -91.2% | +137.3% | -91.2% | +195.5% |
| alltime | all time | -91.2% | +137.3% | -91.2% | +195.5% |
PMV Pharmaceuticals Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $15.21 M(-42.5%) | $15.21 M(-40.6%) |
| Sep 2024 | - | $25.59 M(+10.2%) |
| Jun 2024 | - | $23.22 M(-4.0%) |
| Mar 2024 | - | $24.20 M(-8.6%) |
| Dec 2023 | $26.46 M(+9.0%) | $26.46 M(+13.0%) |
| Sep 2023 | - | $23.41 M(-4.1%) |
| Jun 2023 | - | $24.41 M(+2.6%) |
| Mar 2023 | - | $23.79 M(-2.0%) |
| Dec 2022 | $24.28 M | $24.28 M(+2.1%) |
| Sep 2022 | - | $23.79 M(+0.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2022 | - | $23.59 M(+1.9%) |
| Mar 2022 | - | $23.16 M(+0.7%) |
| Dec 2021 | $23.01 M(+259.0%) | $23.01 M(+19.7%) |
| Sep 2021 | - | $19.23 M(+6.5%) |
| Jun 2021 | - | $18.06 M(+196.2%) |
| Mar 2021 | - | $6.10 M(-4.9%) |
| Dec 2020 | $6.41 M(-96.3%) | $6.41 M(+17.1%) |
| Sep 2020 | - | $5.48 M(+6.4%) |
| Jun 2020 | - | $5.15 M(-97.0%) |
| Dec 2019 | $173.51 M(+58.3%) | $173.51 M |
| Dec 2018 | $109.60 M | - |
FAQ
- What is PMV Pharmaceuticals annual total liabilities?
- What is the all time high annual total liabilities for PMV Pharmaceuticals?
- What is PMV Pharmaceuticals annual total liabilities year-on-year change?
- What is PMV Pharmaceuticals quarterly total liabilities?
- What is the all time high quarterly total liabilities for PMV Pharmaceuticals?
- What is PMV Pharmaceuticals quarterly total liabilities year-on-year change?
What is PMV Pharmaceuticals annual total liabilities?
The current annual total liabilities of PMVP is $15.21 M
What is the all time high annual total liabilities for PMV Pharmaceuticals?
PMV Pharmaceuticals all-time high annual total liabilities is $173.51 M
What is PMV Pharmaceuticals annual total liabilities year-on-year change?
Over the past year, PMVP annual total liabilities has changed by -$11.26 M (-42.53%)
What is PMV Pharmaceuticals quarterly total liabilities?
The current quarterly total liabilities of PMVP is $15.21 M
What is the all time high quarterly total liabilities for PMV Pharmaceuticals?
PMV Pharmaceuticals all-time high quarterly total liabilities is $173.51 M
What is PMV Pharmaceuticals quarterly total liabilities year-on-year change?
Over the past year, PMVP quarterly total liabilities has changed by -$10.38 M (-40.56%)